Cymbalta and PARAESTHESIA

7,391 reports of this reaction

1.7% of all Cymbalta reports

#15 most reported adverse reaction

Overview

PARAESTHESIA is the #15 most commonly reported adverse reaction for Cymbalta, manufactured by Eli Lilly and Company. There are 7,391 FDA adverse event reports linking Cymbalta to PARAESTHESIA. This represents approximately 1.7% of all 439,614 adverse event reports for this drug.

Patients taking Cymbalta who experience paraesthesia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PARAESTHESIA7,391 of 439,614 reports

PARAESTHESIA is a less commonly reported adverse event for Cymbalta, but still significant enough to appear in the safety profile.

Other Side Effects of Cymbalta

In addition to paraesthesia, the following adverse reactions have been reported for Cymbalta:

Frequently Asked Questions

Does Cymbalta cause PARAESTHESIA?

PARAESTHESIA has been reported as an adverse event in 7,391 FDA reports for Cymbalta. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PARAESTHESIA with Cymbalta?

PARAESTHESIA accounts for approximately 1.7% of all adverse event reports for Cymbalta, making it a notable side effect.

What should I do if I experience PARAESTHESIA while taking Cymbalta?

If you experience paraesthesia while taking Cymbalta, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.